Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124743952 | 12474395 | 2 | F | 20160706 | 20160617 | 20160708 | EXP | DK-ROCHE-1777280 | ROCHE | SHARMA M, CARUS A, SUNDE L, DUTOIT -HAMILTON S AND LANDEKARL M BRCA-ASSOCIATED PANCREATICO-BILIARY NEOPLASMS: FOUR CASES ILLUSTRATING THE EMERGING CLINICAL IMPACT OF GENOTYPING.. ACTA ONCOLOGICA 2016;55:377-381. | 41.00 | YR | F | Y | 0.00000 | 20160708 | OT | DK | DK |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124743952 | 12474395 | 1 | PS | CAPECITABINE. | CAPECITABINE | 1 | Unknown | U | 20896 | ||||||||||
| 124743952 | 12474395 | 2 | SS | CARBOPLATIN. | CARBOPLATIN | 1 | Unknown | U | 0 | ||||||||||
| 124743952 | 12474395 | 3 | SS | ETOPOSIDE. | ETOPOSIDE | 1 | Unknown | U | 0 | ||||||||||
| 124743952 | 12474395 | 4 | SS | EVEROLIMUS | EVEROLIMUS | 1 | Unknown | U | 0 | ||||||||||
| 124743952 | 12474395 | 5 | SS | OXALIPLATIN. | OXALIPLATIN | 1 | Unknown | U | 0 | ||||||||||
| 124743952 | 12474395 | 6 | SS | SANDOSTATIN | OCTREOTIDE ACETATE | 1 | Unknown | U | U | 0 | |||||||||
| 124743952 | 12474395 | 7 | C | Bevacizumab | BEVACIZUMAB | 1 | Unknown | 0 | |||||||||||
| 124743952 | 12474395 | 8 | C | SUNITINIB | SUNITINIB | 1 | Unknown | 0 | |||||||||||
| 124743952 | 12474395 | 9 | C | TEMOZOLOMIDE. | TEMOZOLOMIDE | 1 | Unknown | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124743952 | 12474395 | 1 | Neuroendocrine tumour |
| 124743952 | 12474395 | 2 | Neuroendocrine tumour |
| 124743952 | 12474395 | 3 | Neuroendocrine tumour |
| 124743952 | 12474395 | 4 | Neuroendocrine tumour |
| 124743952 | 12474395 | 5 | Neuroendocrine tumour |
| 124743952 | 12474395 | 6 | Ductal adenocarcinoma of pancreas |
| 124743952 | 12474395 | 7 | Neuroendocrine tumour |
| 124743952 | 12474395 | 8 | Neuroendocrine tumour |
| 124743952 | 12474395 | 9 | Neuroendocrine tumour |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124743952 | 12474395 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124743952 | 12474395 | Disease progression | |
| 124743952 | 12474395 | Therapy partial responder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |